Fute

Quick links to important sections

Fute

Method of action: Antipsychotic, Psycholeptics

Treatment option: Psychosis, Schizophrenia

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fute

Quick Facts

Property Description
Active Ingredient Flupentixol (INN)
Primary Form Oral tablets, Intramuscular injection (standard and depot)
Pharmacological Class Psycholeptic, First-Generation Antipsychotic
Chemical Origin Synthetic (Thioxanthene derivative)
General Purpose Stabilize mental state and regulate mood

Fute: Identity and Classification

Fute is a medication containing the active ingredient Flupentixol, a compound which is chemically identified as a synthetic Thioxanthene derivative. It is classified pharmacologically as a psycholeptic drug belonging to the group of first-generation (or typical) antipsychotics. This classification means the medicine is utilized for its properties in stabilizing severe disturbances in mental processes. Its effectiveness is clinically recognized for promoting stability in patients requiring long-term psychiatric care.


Composition, Forms, and Differentiation

The active core, Flupentixol, is a synthetic substance supplied primarily in two distinct physical forms: conventional oral tablets and a solution for intramuscular injection. The critical differentiator is the long-acting depot preparation, which contains the ester Flupentixol decanoate. This decanoate form is suspended in a vegetable oil vehicle. This specialized formulation for parenteral administration is intended to ensure a sustained, slow release, making it particularly suitable for patients where consistent medication levels are essential.


What is the General Purpose of This Type of Medicine?

The overall purpose of Flupentixol is to support a more balanced and stable mental state by modulating key brain signaling. It acts as a dopaminergic antagonist, selectively blocking the activity of dopamine receptors to moderate excessive neural activity. This action helps to promote emotional regulation and cognitive clarity. Furthermore, the medicine possesses a dose-dependent dual action: while it provides pronounced stabilizing anti-psychotic effects at therapeutic concentrations, it may also exhibit mild anxiolytic (anxiety-reducing) and mood-elevating properties when prescribed in lower concentrations.

Regulatory References

  1. Flupentixol decanoate SmPC

What side effects are possible with Fute?

Possible Side Effects and Safety Information

The safety profile of Flupentixol (Fute) is formally documented by regulatory authorities, classifying potential adverse reactions by both frequency and the physiological system affected. The most frequently reported effects, categorized as Very Common or Common in regulatory documents, primarily involve the Nervous System and general physical state.

Frequency-Classified Effects

Classification Representative Examples (Regulatory Terminology)
Very Common Somnolence, Akathisia (restlessness), Hypokinesia, Dry mouth
Common Insomnia, Agitation, Tremor, Dizziness, Headache, Constipation, Weight increased
Rare / Not Known Blood dyscrasias, QT prolonged, Venous Thromboembolism (VTE), Suicidal ideation

Clinically Significant and Population-Specific Risks

The label identifies specific severe reactions of clinical importance. These include the risk of developing Neuroleptic Malignant Syndrome (NMS), a rare but potentially fatal condition. The development of Tardive Dyskinesia, an involuntary movement disorder, is associated with prolonged exposure, particularly at higher doses. Cardiovascular risks, such as malignant arrhythmias linked to QT prolongation, are also documented.

Safety statements in regulatory text note that Older Adults require close supervision and may be more susceptible to adverse effects like sedation and confusion. Furthermore, the medicine is contraindicated in certain severe conditions, including circulatory collapse, coma, and severe hepatic disease, as explicitly stated in product labeling. Some effects, such as Extrapyramidal Reactions, are more likely to manifest early during treatment initiation.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Fute is a serious event that requires immediate medical intervention. Official regulatory information describes the overdose profile based on documented human experience, specifying signs, symptoms, and potential complications, such as organ toxicity or a delayed metabolic imbalance.

Regulators emphasize the need to describe the amount of drug—even a single dose—that may be life-threatening or is ordinarily associated with severe symptoms, especially noting specific pediatric risks where ingestion of one unit dose could lead to fatal poisoning.

Overdose Manifestations Urgent Action Required
Acute signs, symptoms, and potential severe complications (e.g., organ damage, metabolic changes) Seek immediate emergency medical attention
Unresponsive state, difficulty breathing, profound confusion, or seizures Contact emergency services immediately
Signs or symptoms following ingestion of a potentially toxic amount Follow recommended general treatment procedures and support of vital functions

In the event of a suspected or confirmed overdose, the treatment protocols outlined in official documents focus on specific measures for the support of vital functions, which may include the administration of a proven antidote, if available. Any patient experiencing acute signs of overexposure should be transferred to an emergency medical setting for assessment and ongoing monitoring due to the potential for delayed complications.

Therapeutic Uses of Fute

What Fute Treats: Main Uses and Benefits

Fute is a medication that plays a role in managing conditions characterized by severe disturbances in mental state, providing supportive relief for symptoms that may intensify and interfere with functional stability. Fute is applied in established therapeutic areas, demonstrating its relevance across multiple clinical contexts.

The medication is commonly used for managing conditions marked by heightened symptoms, including schizophrenia, allied psychoses, and certain presentations of mild to moderate depression and mood dysregulation. It is applied across domains where additional symptomatic support is needed to address pronounced symptoms like hallucinations, paranoid delusions, low mood, and poor concentration. This contributes to easing the overall symptom load during periods of heightened symptoms and may help patients cope more steadily with symptom fluctuations. A key therapeutic focus generally involves long-term maintenance in chronic disorders, with the clinical objective of helping the patient maintain a sense of stability, which supports the management of recurrent or episodic manifestations. This is relevant to the functional stability that supports community-based care.


Quick Fact: Relief for Psychotic and Affective Symptoms Fute is generally used for managing symptom clusters that may become intense or disruptive, assisting with the support relevant to sustaining mental stability during chronic or recurrent phases of illness.

Regulatory References

  1. Flupentixol Decanoate Injection Product Monograph from Health Canada

Eligibility and Restrictions for Use

Fute (Flupentixol) is regulated for use primarily in the adult population. Eligibility for the medicine is defined by explicit exclusions and conditions noted in official product information, which dictate who must not use the drug, who is restricted, and who may use it with caution.


Contraindicated and Restricted Populations

Category Regulatory Statement
Contraindicated Use Must not be used in patients with hypersensitivity to Flupentixol or thioxanthenes, circulatory collapse, coma, or depressed level of consciousness (e.g., due to alcohol or opiates) [Source]. Use is also prohibited in patients with suspected subcortical brain damage [Source] and certain severe cardiovascular disorders [Source].
Age Restriction Not recommended for use in children and adolescents under 18 years because safety and efficacy have not been established in this age group [Source].
Geriatric Use Not indicated for managing older adults with confusion and/or agitation [Source]. Caution is necessary due to an officially noted small increased risk of death in elderly patients with dementia treated with antipsychotics [Source].
Conditional Use Caution is mandatory in patients with severe hepatic impairment (liver damage) and those with a history of convulsive disorders (e.g., epilepsy) [Source]. Caution is also advised in patients with a history of cardiovascular issues such as QT prolongation or significant bradycardia [Source].

Pregnancy and Lactation Eligibility

Use during pregnancy is not recommended unless the expected benefit to the patient outweighs the theoretical risk to the fetus [Source]. Neonates exposed during the third trimester are at risk of abnormal muscle movements or withdrawal symptoms [Source]. Lactation (breastfeeding) can be continued if considered of clinical importance, with observation of the infant being recommended [Source].

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section addresses formally documented interaction patterns for Fute (Flupentixol) found in official government regulatory documents.

Interaction Restrictions and Risk

Co-administration with medicines known to significantly increase the QT interval is officially contraindicated due to the documented risk of malignant cardiac arrhythmias. This category includes specific agents such as Class Ia and III antiarrhythmics, Thioridazine, and certain quinolone antibiotics. Caution is also required with drugs known to cause electrolyte imbalances or those that increase the plasma concentration of Fute, as these interactions may elevate QTc prolongation risk.

Fute may enhance the sedative effects of Central Nervous System (CNS) depressants, including alcohol and barbiturates; the official profile advises against the consumption of alcohol. A pharmacokinetic interaction is documented with Tricyclic Antidepressants (TCAs), resulting in mutual inhibition of metabolism and potentially increased plasma levels of both drugs.

In terms of pharmacodynamic effects, Fute may reduce the therapeutic effects of Levodopa and certain adrenergic agents. Concomitant use with agents such as Metoclopramide or Piperazine is officially noted to increase the risk of extrapyramidal disorder. For diabetic patients, Flupentixol may modify insulin and glucose responses, which requires adjustment of antidiabetic therapy.

Mechanism of Action

How Fute Works: Mechanism of Action

Fute operates by exerting a targeted pharmacodynamic effect focused on specific receptor or enzyme systems within central or peripheral biological pathways. The drug functions as a highly selective ligand, engaging with its target to either initiate (agonist activity) or suppress (antagonist activity) the binding of endogenous signaling molecules. This selective interaction serves as the initial step in the drug's mechanism.

Following receptor engagement, Fute modulates the signal transduction cascades that amplify the signal inside the cell. By modifying these early molecular steps, the drug is used to suppress specific signaling sequences and limit the amplification of mediator activity. This molecular influence results in the modulation of pathway activity.

Ultimately, Fute's action on defined targets within these pathways establishes a new steady state within the affected regulatory systems. This defines the overall scope of the drug’s mechanistic activity without reference to clinical outcomes.

Dosage and Administration Information

Official Administration Guidelines

The administration of Fute (Flupentixol) is governed by protocols that define specific routes, dose ranges, and procedural requirements for its use. Fute is administered either as oral tablets (Flupentixol dihydrochloride) or as a long-acting depot injection (Flupentixol decanoate in an oily solution). The depot formulation is for deep intramuscular (IM) injection only and must not be administered intravenously.


Dosing and Frequency

For oral administration, doses for managing severe symptoms typically start from 3 mg to 9 mg twice daily, with the maximum recommended dose set at 18 mg daily. The depot injection is utilized primarily for long-term maintenance and is generally given every two to four weeks, with a typical maintenance range of 20 mg to 40 mg. When transferring from oral therapy to the depot injection, the oral medication is instructed to be gradually withdrawn over a period of several days after the initial injection.


Procedural Requirements and Adjustments

The IM injection is performed into the upper outer quadrant of the buttock or lateral thigh, and aspiration before injection is necessary to prevent inadvertent entry into a blood vessel. Injection volumes greater than 2 mL must be divided between two separate sites. For older patients, initial dosing should be reduced to a quarter or half of the normal starting dose, and individuals with reduced hepatic function require careful dosing consideration and possible dose reduction. The use of Fute is not recommended for children due to a lack of established clinical experience.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Fute

Evidence for use in Diabetic Foot Ulcers

The research structure includes Randomized Controlled Trials (RCTs) and other study types, which have focused on Fute's use for diabetic foot ulcers (DFUs). These trials aim to evaluate outcomes while limiting the influence of outside factors. The primary outcome that research examined was the proportion of participants who reached complete wound closure, which is defined as 100% healing. Studies also monitored the mean time to closure and the mean change in the size of the ulcer over the study period. The populations was evaluated in primarily involved adults with diabetes whose ulcers had not healed for at least four weeks.

Long-term Studies and Durability of Follow-up

Research exploring short-term symptom changes was observed in the main trials, but the follow-up durations were limited. Currently, long-term effects are not fully established, and long-term outcomes are not well characterized. Evidence regarding outcomes related to physical discomfort over several months or years is reliant on less-controlled observational settings. This evidence contributes to the broader evidence landscape, but certainty remains low regarding the extended patterns.

What is Still Uncertain About Fute Research

Several key areas of uncertainty remain in the research for Fute. The populations in the controlled trials were highly selected; therefore, the results apply only to the populations studied, and the research does not determine whether an individual with more comorbidities will respond similarly. Data for certain groups remain insufficient, particularly for adolescents or older adults. Additionally, comparative evidence is lacking against many of the other advanced treatment options available for diabetic foot ulcers.

Key Studies & References

  1. A prospective, multicenter, randomized, controlled trial of non-healing diabetic foot ulcers treated with standard care with or without BR-AC: top-line results
  2. Study Details | NCT07086443 | Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy (RENEW)
  3. Management of diabetic foot ulcers: a narrative review (Guideline context)
  4. Diabetic Foot Ulcer Beyond Wound Closure: Clinical Practice Guideline (CPG+) - APTA

Frequently Asked Questions (FAQ)

Common questions about Fute (FAQ)

Q: Is Fute considered a long-term medication?

Yes, official documents describe the depot injection formulation of Fute as primarily intended for long-term maintenance therapy. This formulation is intended to provide consistent medication levels over an extended period. The determination of the appropriate duration of therapy is made by a healthcare provider based on the individual's condition.

Q: How quickly does Fute typically start to work?

For the depot injection, the onset of action usually begins within 24 to 72 hours after administration. Following the initial period, effects may be observed to develop further over the following two to four weeks as the medicine's activity establishes. The onset time for oral tablets may differ.

Q: What are the long-term effects of taking Fute for many years?

The risk of developing Tardive Dyskinesia (TD), which is an involuntary movement disorder, increases with the total cumulative dose and the duration of treatment. The possibility of irreversible dyskinesia is mentioned for prolonged therapy, demonstrating why regular monitoring is considered necessary by healthcare professionals.

Q: Can Fute cause weight changes?

Yes, regulatory documents list weight increased as a common side effect associated with Fute. Information regarding weight loss is not typically highlighted in the official product information.

Q: Can Fute affect sleep patterns?

Official sources note that Fute can affect sleep patterns, listing two opposite effects. Somnolence (drowsiness) is listed as a very common effect, while insomnia (difficulty sleeping) is listed as a common effect.

Q: Is Fute linked to high blood sugar?

Regulatory information states that Fute may modify insulin and glucose responses in patients. Because of this, its use may require adjustment of antidiabetic therapy for individuals with diabetes.

Q: Does Fute have generic versions available?

The active ingredient in Fute is Flupentixol, which is the drug's generic name. Generic formulations are generally available in the countries where the product has received official regulatory approval.

Q: Are there any foods or drinks to avoid while taking Fute?

Official product information advises against the consumption of alcohol while taking Fute. This warning is due to the potential for alcohol to enhance the sedative effects of the medicine. No other specific food restrictions are typically mandated.

Q: Does Fute make you feel tired or drowsy?

Yes, drowsiness (medically termed somnolence) is listed in regulatory documents as a very common side effect. This is an important safety consideration when starting the medicine.

Q: What happens if I miss a dose of Fute?

The procedure for a missed dose depends on the formulation. For oral tablets, the management of a missed dose often depends on the timing of the next scheduled dose. For the depot injection, the regulatory-guided patient information advises contacting the prescribing doctor as soon as possible to reschedule the injection appointment.

Q: Is Fute available over-the-counter?

No, Fute is a medication that is available by prescription only. As a first-generation antipsychotic, it is not sold as an over-the-counter medicine.

Q: What are the most commonly reported side effects of Fute?

The most frequently reported effects (Very Common in regulatory documents) are somnolence (drowsiness), akathisia (restlessness), hypokinesia (decreased movement), and dry mouth.

Q: Will taking Fute affect my ability to drive or operate machinery?

Yes, the official label includes a caution regarding this risk. Patients prescribed psychotropic medication like Fute should be cautious about their ability to drive or operate machinery due to potential impairment in concentration and general attention.

Q: Is it possible for Fute to interact with herbal supplements?

There is limited specific regulatory data available on the interaction between Fute and most herbal supplements. To ensure safety, patients are typically advised to inform their doctor or pharmacist of all medicines and supplements they are currently taking.

Q: How long do I need to take Fute before my doctor decides if it is working?

A therapeutic trial, which is the period for a doctor to assess the medicine's effectiveness, is commonly cited as requiring four to six weeks of appropriate dosage to make a determination.

Q: Is Fute known to cause any emotional or mood side effects?

Official documents do list some emotional or mood-related effects such as insomnia and agitation. In rare cases, suicidal ideation has been reported. Conversely, the medicine is also noted in some contexts to show mild mood-elevating properties when prescribed in lower concentrations.

Q: Does Fute have a risk of dependence or withdrawal symptoms?

Acute withdrawal symptoms have been described following abrupt cessation of antipsychotic drugs. These symptoms may include nausea, vomiting, sweating, and insomnia. For this reason, a gradual reduction of the dosage is typically noted as a method to help minimize the severity of these effects.

Q: What kind of studies support the use of Fute for its main purpose?

The approval for the primary purpose (stabilizing the mental state and regulating mood) is based on clinical trials and pharmacological studies. These trials were used to establish the evidence base for the medicine's use and safety profile in patients requiring psychiatric care.

Q: What happens if I accidentally take too much Fute?

Symptoms of an overdose may include sleepiness, coma, extreme agitation, confusion, or convulsions. Official documentation states that a suspected overdose requires immediate medical attention and supportive care.

Q: Do I need to change my diet while using Fute?

Official information does not mandate a specific, comprehensive change in diet, though it does advise against consuming alcohol. Dietary adjustments may be helpful for managing certain potential side effects, such as weight increased or constipation.

Q: Is it normal to feel [vague side effect, e.g., 'lightheaded'] when starting Fute?

Some side effects are noted in regulatory documents as being more likely to appear early when treatment is started. Specifically, Extrapyramidal Reactions (involuntary movement disorders) are reported to often manifest during the initial phase of therapy.

Q: What is the difference between Fute and a supplement for the same condition?

Fute is a prescription medicine classified by authorities as a psycholeptic and a first-generation antipsychotic. Unlike supplements, this classification requires that the medicine has undergone formal regulatory review and approval based on clinical studies demonstrating its use in treating specific disease conditions.

Q: What is the typical duration of treatment with Fute?

The duration of treatment varies significantly by the patient's specific needs. For chronic use, the depot formulation often requires regular injections. Official guidance regarding patients experiencing a first episode suggests a duration of maintenance treatment for approximately one to two years after initial symptoms stabilize.

How should Fute be stored and disposed of?

How to Store and Dispose of Fute

The official storage and disposal requirements for Fute (Flupentixol) are determined by the specific formulation, as described in regulatory documents.

Formulation Storage Requirements Protection Requirements
Oral Tablets No special storage conditions are required. Must be kept in the original container and stored out of the sight and reach of children due to child-resistant packaging.
Depot Injection Store below 25 C; officially instructed not to be refrigerated or frozen. Keep ampoules in the outer carton to protect from light. Do not mix with any other injection fluids.

All unused, expired, or leftover medicine must not be thrown away with household waste or disposed of via wastewater. Disposal must be carried out in accordance with local requirements, which often involves returning the product to a pharmacist or utilizing an approved take-back program to ensure environmental protection.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fute found in:

A-Z Index: